| Stage | H | % of rev | MORN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.7B | 100.00% | $672M | 100.00% | H ×2.59 |
| Gross profit | $384M | 22.03% | $431M | 64.19% | MORN +42.2pp |
| Operating income | $138M | 7.92% | $167M | 24.91% | MORN +17.0pp |
| Pre-tax income | $79M | 4.53% | $152M | 22.68% | MORN +18.1pp |
| Net income | $61M | 3.50% | $116M | 17.18% | MORN +13.7pp |
| Stage | H | MORN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.7B100.00% | $672M100.00% | H ×2.59 |
| Gross profit | 22.03%$384M | 64.19%$431M | MORN +42.2pp |
| Operating income | 7.92%$138M | 24.91%$167M | MORN +17.0pp |
| Pre-tax income | 4.53%$79M | 22.68%$152M | MORN +18.1pp |
| Net income |
| 3.50%$61M |
| 17.18%$116M |
| MORN +13.7pp |
No shared counterparties.